Adipopharma Trademark Application Published for Opposition
Summary
The USPTO has published the Adipopharma trademark application (TM79425256) for opposition. The application covers scientific and technological services related to drugs and pharmaceuticals, as well as various pharmaceutical and veterinary preparations.
What changed
The United States Patent and Trademark Office (USPTO) has published the trademark application for 'Adipopharma' (TM79425256) for a 30-day opposition period, which began on March 26, 2026. The application seeks to register trademarks for a wide range of scientific and technological services related to drug and pharmaceutical research and development, as well as specific pharmaceutical and veterinary preparations for treating various diseases and disorders.
This publication signifies that the application has passed initial examination and is now open for any party to oppose its registration. Companies operating in the pharmaceutical and biotechnology sectors should monitor this application if they have similar existing trademarks or are concerned about potential market confusion. No immediate compliance actions are required for entities other than potential opposers, but it is a step towards potential market exclusivity for the applicant.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
ADIPOPHARMA
Published for Opposition TM79425256 Kind: published Mar 26, 2026
Abstract
Scientific and technological services, namely, research and design relating to drugs, pharmaceuticals, medicine; research and development services in the field of pharmacy and in particular medicines; research and development of new products for third parties; biological research; bacteriological research; chemical research; cosmetic science research; technical research in the field of new product development; scientific laboratory services; chemical analysis; material testing; technical project studies namely, conducting of feasibility studies in the field of new technologies; surveying being engineering services, engineering; Pharmaceutical and veterinary preparations for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; medications for human medicine for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; chemical preparations for medical use for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; chemical preparations for pharmaceutical use for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; diagnostic preparations for medical use; cultures of microorganisms for medical use; stem cells for medical use; sanitary preparations for medical purposes; foodstuffs and dietetic food and beverages adapted for medical or veterinary use
Filing Date
2025-04-01
Related changes
Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.